NEOGENOMICS, INC. (NEO) capitalization

Current snapshot

Market Cap
$966.2M
130.2M shares × $7.42 · as of last filing 2026-03-31
Net Worth
$828.8M
Stockholders' equity · 2026-03-31
Enterprise Value
$1.23B
Market cap + debt − cash
Net Debt
$262.4M
Debt $408.5M − Cash $146.1M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $1.51B
FY'24 2024-12-31 $2.09B
FY'23 2023-12-31 $2.03B
FY'22 2022-12-31 $1.15B
FY'21 2021-12-31 $4.09B
FY'20 2020-12-31 $6.02B
FY'19 2019-12-31 $3.03B
FY'18 2018-12-31 $1.15B
FY'17 2017-12-31 $703.7M
FY'16 2016-12-31 $664.5M
FY'15 2015-12-31 $476.3M
FY'14 2014-12-31 $233.6M
FY'13 2013-12-31 $191.0M
FY'12 2012-12-31 $120.8M
FY'11 2011-12-31 $59.9M
FY'11 2010-12-31 $48.7M

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $958.4M
Q4'25 2025-12-31 $1.52B
Q3'25 2025-09-30 $991.4M
Q2'25 2025-06-30 $935.3M
Q1'25 2025-03-31 $1.21B
Q4'24 2024-12-31 $2.11B
Q3'24 2024-09-30 $1.87B
Q2'24 2024-06-30 $1.75B
Q1'24 2024-03-31 $1.98B
Q4'23 2023-12-31 $2.06B
Q3'23 2023-09-30 $1.55B
Q2'23 2023-06-30 $2.01B
Q1'23 2023-03-31 $2.18B
Q4'22 2022-12-31 $1.17B
Q3'22 2022-09-30 $1.07B
Q2'22 2022-06-30 $1.01B
Q1'22 2022-03-31 $1.50B
Q4'21 2021-12-31 $4.23B
Q3'21 2021-09-30 $5.91B
Q2'21 2021-06-30 $5.93B
Q1'21 2021-03-31 $5.60B
Q4'20 2020-12-31 $6.03B
Q3'20 2020-09-30 $4.40B
Q2'20 2020-06-30 $3.34B
Q1'20 2020-03-31 $2.88B
Q4'19 2019-12-31 $3.06B
Q3'19 2019-09-30 $2.06B
Q2'19 2019-06-30 $2.25B
Q1'19 2019-03-31 $1.94B
Q4'18 2018-12-31 $1.19B
Q3'18 2018-09-30 $1.40B
Q2'18 2018-06-30 $1.18B
Q1'18 2018-03-31 $656.9M
Q4'17 2017-12-31 $712.9M
Q3'17 2017-09-30 $886.1M
Q2'17 2017-06-30 $711.5M
Q1'17 2017-03-31 $620.5M
Q4'16 2016-12-31 $673.4M
Q3'16 2016-09-30 $642.4M
Q2'16 2016-06-30 $622.7M
Q1'16 2016-03-31 $512.7M
Q4'15 2015-12-31 $596.7M
Q3'15 2015-09-30 $346.9M
Q2'15 2015-06-30 $326.9M
Q1'15 2015-03-31 $281.5M
Q4'14 2014-12-31 $251.2M
Q3'14 2014-09-30 $283.7M
Q2'14 2014-06-30 $178.4M
Q1'14 2014-03-31 $185.5M
Q4'13 2013-12-31 $177.8M
Q3'13 2013-09-30 $159.5M
Q2'13 2013-06-30 $213.9M
Q1'13 2013-03-31 $200.1M
Q4'12 2012-12-31 $112.3M
Q3'12 2012-09-30 $136.0M
Q2'12 2012-06-30 $81.0M
Q1'12 2012-03-31 $80.1M
Q4'11 2011-12-31 $60.8M
Q3'11 2011-09-30 $45.3M
Q2'11 2011-06-30 $55.7M
Q1'12 2011-03-31 $57.2M
Q4'11 2010-12-31 $48.7M
Q3'11 2010-09-30
Q2'11 2010-06-30

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (NEO CIK 0001077183), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

QNCX

Quince Therapeutics, Inc.

ARDX

ARDELYX, INC.

GSHD

GOOSEHEAD INSURANCE, INC.